Free tool
Healthcare stocks
We cover 126 companies in the Healthcare sector. The median market value in the group is $1.08B. Across the group, the median move over the past trading day is +0.85%. 54% of the 119 with a 200-day average trade above it. Price change over the past year runs from −46.0% to +63.3% across the middle 80 percent of the group, with a median of −2.7%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
126 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% | Oct 29, 2026 |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% | Nov 3, 2026 |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% | Oct 20, 2026 |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +41.64% | Nov 2, 2026 |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +50.84% | Oct 29, 2026 |
| IUI1.DE | Intuitive Surgical, Inc. | $131.98B | Large cap | −21.06% | Oct 20, 2026 |
| SYK.DE | Stryker Corporation | $126.78B | Large cap | +34.90% | Oct 29, 2026 |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% | Sep 1, 2026 |
| SNW.DE | Sanofi | $109.40B | Large cap | −2.82% | Oct 30, 2026 |
| SAN.PA | Sanofi | $109.36B | Large cap | −2.60% | Oct 30, 2026 |
| GSK.L | GSK plc | $104.16B | Large cap | +30.59% | Oct 28, 2026 |
| GS71.DE | GSK plc | $103.63B | Large cap | +34.79% | Oct 28, 2026 |
| A58.DE | Elevance Health, Inc. | $87.59B | Large cap | −19.30% | Oct 21, 2026 |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | −5.91% | Oct 28, 2026 |
| CGN.DE | The Cigna Group | $74.86B | Large cap | −8.78% | Nov 5, 2026 |
| BSX.DE | Boston Scientific Corporation | $69.12B | Large cap | −53.11% | Oct 28, 2026 |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% | Nov 5, 2026 |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +76.91% | Nov 3, 2026 |
| BAY.WA | Bayer Aktiengesellschaft | $55.90B | Large cap | +76.59% | Nov 3, 2026 |
| EWL.DE | Edwards Lifesciences Corporation | $52.39B | Large cap | +11.65% | Oct 29, 2026 |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% | Nov 5, 2026 |
| IX1.DE | IDEXX Laboratories, Inc. | $44.14B | Large cap | +17.97% | Nov 2, 2026 |
| 2U3.DE | Alcon Inc. | $35.20B | Large cap | −7.70% | Nov 10, 2026 |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% | Oct 29, 2026 |
| DC4.DE | DexCom, Inc. | $33.35B | Large cap | +21.06% | Oct 29, 2026 |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +65.32% | Oct 29, 2026 |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | $32.28B | Large cap | −10.21% | Oct 29, 2026 |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% | Nov 3, 2026 |
| FRE.DE | Fresenius SE & Co. KGaA | $30.43B | Large cap | +1.64% | Nov 4, 2026 |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +14.09% | Nov 3, 2026 |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% | Oct 22, 2026 |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% | Oct 22, 2026 |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% | Nov 5, 2026 |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% | Nov 5, 2026 |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +67.32% | Nov 5, 2026 |
| QS51.DE | Straumann Holding AG | $18.40B | Large cap | −1.10% | Oct 28, 2026 |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% | Oct 27, 2026 |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | −20.60% | Nov 3, 2026 |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +7.91% | Nov 3, 2026 |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% | Oct 22, 2026 |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% | Oct 28, 2026 |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | −2.61% | Nov 3, 2026 |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% | Nov 10, 2026 |
| AFW.DE | Align Technology, Inc. | $11.26B | Large cap | −54.37% | Oct 28, 2026 |
| ABVX.PA | ABIVAX Société Anonyme | $10.21B | Large cap | +48.91% | Sep 21, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% | Oct 22, 2026 |
| EMBLA.CO | Embla Medical hf. | $1.93B | Small cap | −6.94% | Oct 20, 2026 |
| GXE.DE | Lakefront Biotherapeutics NV | $1.93B | Small cap | −44.50% | Nov 12, 2026 |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% | Nov 6, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.57B | Small cap | −28.26% | Oct 22, 2026 |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% | Sep 10, 2026 |
| NOLA-B.ST | Nolato AB (publ) | $1.50B | Small cap | −7.00% | Oct 29, 2026 |
| RDC.DE | Redcare Pharmacy NV | $1.49B | Small cap | −23.82% | Oct 29, 2026 |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% | Nov 4, 2026 |
| GDS.PA | Ramsay Générale de Santé SA | $1.42B | Small cap | +9.50% | Oct 16, 2026 |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% | Oct 22, 2026 |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% | Sep 9, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% | Oct 22, 2026 |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% | Sep 24, 2026 |
| IVA.PA | Inventiva S.A. | $1.14B | Small cap | −14.63% | Sep 25, 2026 |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.14B | Small cap | +24.49% | Nov 5, 2026 |
| TTALO.HE | Terveystalo Oyj | $1.14B | Small cap | −22.31% | Oct 21, 2026 |
| GUBRA.CO | Gubra A/S | $1.02B | Small cap | +4.79% | Nov 6, 2026 |
| VETO.PA | Vetoquinol SA | $973.12M | Small cap | −6.37% | Sep 11, 2026 |
| EUZ.DE | Eckert & Ziegler SE | $952.11M | Small cap | −24.60% | Nov 12, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $929.27M | Small cap | +59.31% | Oct 22, 2026 |
| DBV.PA | DBV Technologies S.A. | $901.25M | Small cap | +60.13% | Oct 28, 2026 |
| SYNSAM.ST | Synsam AB (publ) | $873.75M | Small cap | +5.66% | Nov 12, 2026 |
| MCAP.ST | MedCap AB (publ) | $864.73M | Small cap | −10.28% | Oct 23, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% | Oct 21, 2026 |
| OXB.L | Oxford Biomedica plc | $847.14M | Small cap | −9.81% | Sep 23, 2026 |
| GNFT.PA | Genfit S.A. | $830.56M | Small cap | +310.45% | Sep 29, 2026 |
| APOTEA.ST | Apotea AB (publ) | $822.73M | Small cap | −26.38% | Nov 5, 2026 |
| ARJO-B.ST | Arjo AB (publ) | $802.95M | Small cap | −15.25% | Oct 22, 2026 |
| UU8.F | Neurogene Inc. | $795.50M | Small cap | +165.60% | Nov 12, 2026 |
| EVT.DE | Evotec SE | $694.87M | Small cap | −45.75% | Nov 5, 2026 |
| EQS.PA | Equasens Société anonyme | $588.00M | Small cap | −25.98% | Sep 28, 2026 |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $564.79M | Small cap | −29.98% | Nov 3, 2026 |
| MEDI.OL | Medistim ASA | $512.66M | Small cap | +4.43% | Oct 23, 2026 |
| REG1V.HE | Revenio Group Oyj | $494.52M | Small cap | −38.54% | Sep 8, 2026 |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% | Nov 5, 2026 |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% | Oct 28, 2026 |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% | Sep 29, 2026 |
| EGTX.ST | Egetis Therapeutics AB (publ) | $390.51M | Small cap | +51.35% | Nov 6, 2026 |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% | Aug 31, 2026 |
| ALCLS.PA | Cellectis S.A. | $355.75M | Small cap | +27.74% | Nov 13, 2026 |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% | Oct 22, 2026 |
| ILM1.DE | Medios AG | $324.14M | Small cap | −26.32% | Nov 10, 2026 |
| SBS.DE | Stratec SE | $322.43M | Small cap | −16.91% | Nov 12, 2026 |
| VICO.ST | Vicore Pharma Holding AB (publ) | $315.07M | Small cap | −1.29% | Nov 5, 2026 |
| PIHLIS.HE | Pihlajalinna Oyj | $283.18M | Small cap | −28.38% | Oct 28, 2026 |
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% | Nov 12, 2026 |
| TRMED.OL | Thor Medical ASA | $268.94M | Small cap | +135.13% | Aug 28, 2026 |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% | Sep 29, 2026 |
| IDD.DE | Innate Pharma S.A. | $243.27M | Small cap | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | $240.15M | Small cap | +1.19% | Sep 17, 2026 |
| NORDH.OL | Nordhealth AS | $204.13M | Small cap | −32.22% | Nov 10, 2026 |
| ORIOLA.HE | Oriola Oyj | $195.27M | Small cap | −21.98% | Oct 29, 2026 |
| ALCGM.PA | Cegedim SA | $166.24M | Small cap | −4.56% | Sep 24, 2026 |
| PHO.OL | Photocure ASA | $157.00M | Small cap | −13.46% | Oct 28, 2026 |
| BICO.ST | BICO Group AB (publ) | $147.45M | Small cap | −17.00% | Nov 11, 2026 |
| SEDANA.ST | Sedana Medical AB (publ) | $132.45M | Small cap | −22.05% | Oct 22, 2026 |
| MVIR.ST | Medivir AB (publ) | $131.70M | Small cap | +4.73% | Nov 5, 2026 |
| AZT.OL | ArcticZymes Technologies ASA | $110.96M | Small cap | −27.02% | Nov 5, 2026 |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $105.23M | Small cap | −60.78% | Nov 3, 2026 |
| NANOFH.HE | Nanoform Finland Oyj | $95.78M | Micro cap | +15.66% | Nov 11, 2026 |
| NANOFS.ST | Nanoform Finland Oyj | $93.63M | Micro cap | +19.56% | Nov 11, 2026 |
| VISTN.OL | Vistin Pharma ASA | $91.60M | Micro cap | −15.42% | Oct 29, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | $88.75M | Micro cap | −47.94% | Sep 28, 2026 |
| ZLNA.OL | Zelluna ASA | $70.31M | Micro cap | +56.57% | Nov 5, 2026 |
| SEZI.ST | Senzime AB (publ) | $61.48M | Micro cap | −39.98% | Oct 29, 2026 |
| FLUO.ST | FluoGuide A/S | $53.21M | Micro cap | −18.34% | Nov 26, 2026 |
| BACTI-B.ST | Bactiguard Holding AB (publ) | $52.93M | Micro cap | −46.25% | Oct 22, 2026 |
| CANTA.ST | Cantargia AB (publ) | $51.16M | Micro cap | −27.38% | Nov 25, 2026 |
| AIFORIA.HE | Aiforia Technologies Oyj | $49.78M | Micro cap | −60.34% | Aug 28, 2026 |
| ORX.ST | Orexo AB (publ) | $48.90M | Micro cap | −35.06% | Oct 22, 2026 |
| OSSD.ST | OssDsign AB (publ) | $44.89M | Micro cap | −73.26% | Nov 3, 2026 |
| OPTOMED.HE | Optomed Oyj | $41.93M | Micro cap | −54.39% | Nov 6, 2026 |
| IVACC.ST | Intervacc AB (publ) | $38.50M | Micro cap | +4.78% | Nov 12, 2026 |
| NAVA.OL | Navamedic ASA | $37.60M | Micro cap | −32.27% | Oct 29, 2026 |
| PSH0.DE | Sernova Biotherapeutics Inc | $30.82M | Micro cap | −27.68% | Sep 10, 2026 |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% | Sep 3, 2026 |
| AELIS.PA | Aelis Farma SA | $16.34M | Micro cap | −19.22% | Sep 15, 2026 |
| VIVE.ST | Vivesto AB | $10.39M | Micro cap | −57.13% | Nov 12, 2026 |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | $3.19M | Micro cap | −93.99% | Nov 12, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.